doi:10.1016/j.virs.2022.07.014

[1]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[2]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[3]
Chunchen Wu, Wenzhong Yang, Xiaoxue Wu, Tianzhu Zhang, Yaoyao Zhao, Wei Ren, Jianbo Xia, 2020: Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women, Virologica Sinica, 35, 305-310. doi: 10.1007/s12250-020-00227-0
[4]
Yafei Zhang, Changtai Wang, Mingfeng Han, Jun Ye, Yong Gao, Zhongping Liu, Tengfei He, Tuantuan Li, Mengyuan Xu, Luping Zhou, Guizhou Zou, Mengji Lu, Zhenhua Zhang, 2020: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference, Virologica Sinica, 35, 758-767. doi: 10.1007/s12250-020-00273-8
[5]
Peng Zhou, Zhenggang Han, Lin-Fa Wang, Zhengli Shi, 2013: Identification of Immunogenic Determinants of the Spike Protein of SARS-like Coronavirus, Virologica Sinica, 28, 92-96. doi: 10.1007/s12250-013-3292-y
[6]
Haili Zhang, Hongli Jin, Feihu Yan, Yumeng Song, Jiaxin Dai, Cuicui Jiao, Yujie Bai, Jingxuan Sun, Di Liu, Shen Wang, Mengyao Zhang, Jilong Lu, Jingbo Huang, Pei Huang, Yuanyuan Li, Xianzhu Xia, Hualei Wang, 2023: An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV, Virologica Sinica, 38, 244-256. doi: 10.1016/j.virs.2022.12.006
[7]
Jianchun Wei, Hui Chen, Jing An, 2014: Recent progress in dengue vaccine development, Virologica Sinica, 29, 353-363. doi: 10.1007/s12250-014-3542-7
[8]
肖春惠, 杨占秋, 2001: The Development of The Hantan Virus Vaccine, Virologica Sinica, 16, 299-303.
[9]
Lianxing Liu, Chao Qiu, Yang Huang, Jianqing Xu, Yiming Shao, 2013: Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine, Virologica Sinica, 28, 109-115. doi: 10.1007/s12250-013-3303-z
[10]
Karen A O Martins, Travis K Warren, Sina Bavari, 2013: Characterization of a Putative Filovirus Vaccine: Virus-Like Particles, Virologica Sinica, 28, 65-70. doi: 10.1007/s12250-013-3306-9
[11]
Ling Tao, JianJun Chen, Jin Meng, Yao Chen, Hongxia Li, Yan Liu, Zhenhua Zheng, Hanzhong Wang, 2013: Enhanced Protective Efficacy of H5 Subtype Influenza Vaccine with Modification of the Multibasic Cleavage Site of Hemagglutinin in Retroviral Pseudotypes, Virologica Sinica, 28, 136-145. doi: 10.1007/s12250-013-3326-5
[12]
Kaissar Tabynov, Zhailaubai Kydyrbayev, Abylai Sansyzbay, Berik Khairullin, Sholpan Ryskeldinova, Nurika Assanzhanova, Yerken Kozhamkulov, Dulat Inkarbekov, 2012: Immunogenic and Protective Properties of the First Kazakhstan Vaccine against Pandemic Influenza A(H1N1) pdm09 in Ferrets, Virologica Sinica, 27, 345-352. doi: 10.1007/s12250-012-3272-7
[13]
Julian Ruiz-Sáenz, Jairo Jaime, Victor Vera, 2013: An Inactivated Vaccine from a Field Strain of Bovine Herpesvirus-1 (BoHV-1) has High Antigenic Mass and Induces Strong Efficacy in a Rabbit Model, Virologica Sinica, 28, 36-42. doi: 10.1007/s12250-013-3283-z
[14]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[15]
Xiao-Li Feng, Dandan Yu, Mi Zhang, Xiaohong Li, Qing-Cui Zou, Wentai Ma, Jian-Bao Han, Ling Xu, Cuixian Yang, Wang Qu, Zhong-Hua Deng, Junyi Long, Yanghaopeng Long, Mingkun Li, Yong-Gang Yao, Xing-Qi Dong, Jianxiong Zeng, Ming-Hua Li, 2022: Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates, Virologica Sinica, 37, 804-812. doi: 10.1016/j.virs.2022.09.007
[16]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
[17]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029
[18]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[19]
Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8
[20]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006